The American Journal of Surgery
Volume 193, Issue 4 , Pages 460-465 , April 2007

Surgical treatment of pancreatic endocrine neoplasms

  • Fernando Gomez-Rivera, M.D.

      Affiliations

    • Section of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, 1922 7th Avenue South, Room 321, Birmingham, AL, USA
    • ,
  • Ashley E. Stewart, M.D.

      Affiliations

    • Section of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, 1922 7th Avenue South, Room 321, Birmingham, AL, USA
    • ,
  • J. Pablo Arnoletti, M.D.

      Affiliations

    • Section of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, 1922 7th Avenue South, Room 321, Birmingham, AL, USA
    • ,
  • Selwyn Vickers, M.D.

      Affiliations

    • Section of Gastrointestinal Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA
    • ,
  • Kirby I. Bland, M.D.

      Affiliations

    • Section of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, 1922 7th Avenue South, Room 321, Birmingham, AL, USA
    • ,
  • Martin J. Heslin, M.D.

      Affiliations

    • Section of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, 1922 7th Avenue South, Room 321, Birmingham, AL, USA
    • Corresponding Author InformationCorresponding author. Department of Surgery, Section of Surgical Oncology, University of Alabama at Birmingham, 321 Kracke Building, 1922 7th Ave. S., Birmingham, AL 35294. Tel.: (205) 934-3064; fax: (205) 975-5971.

Received 24 July 2006 ,Revised 16 October 2006

References 

  1. Muscarella P, Ellison EC. Pancreatic islet cell tumors excluding gastrinoma. In:  Cameron JL editors. Current Surgical Therapy. Philadelphia, PA: Elsevier Mosby; 2004;p. 520–525
  2. Azimuddin K, Chamberlain RS. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am. 2001;81:511–525
  3. Liang H, Wang P, Wang XN, et al. Management of nonfunctioning islet cell tumors. World J Gastroenterol. 2004;10:1806–1809
  4. Madeira I, Terris B, Voss M, et al. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut. 1998;43:422–427
  5. Matthews BD, Smith TI, Kercher KW, et al. Surgical experience with functioning pancreatic neuroendocrine tumors. Am Surg. 2002;68:660–665
  6. Pape UF, Bohmig M, Berndt U, et al. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center. Ann N Y Acad Sci. 2004;1014:222–233
  7. Phan GQ, Yeo CJ, Hruban RH, et al. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg. 1998;2:472–482
  8. Chu QD, Hill HC, Douglass HO, et al. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas. Ann Surg Oncol. 2002;9:855–862
  9. Eckhauser FE, Cheung PS, Vinik AI, et al. Nonfunctioning malignant neuroendocrine tumors of the pancreas. Surgery. 1986;100:978–988
  10. Legaspi A, Brennan MF. Management of islet cell carcinoma. Surgery. 1988;104:1018–1023
  11. McEntee GP, Nagorney DM, Kvols LK, et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990;108:1091–1096
  12. Norton JA, Sugarbaker PH, Doppman JL, et al. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg. 1986;203:352–359
  13. Thompson GB, van Heerden JA, Grant CS, et al. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. 1988;104:1011–1017
  14. Norton JA, Kivlen M, Li M, et al. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Arch Surg. 2003;138:859–866
  15. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg. 2000;190:432–445
  16. Touzios JG, Kiely JM, Pitt SC, et al. Neuroendocrine hepatic metastases: does aggressive management improve survival?. Ann Surg. 2005;241:776–783
  17. Lo CY, van Heerden JA, Thompson GB, et al. Islet cell carcinoma of the pancreas. World J Surg. 1996;20:878–883
  18. Grama D, Eriksson B, Martensson H, et al. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg. 1992;16:632–639
  19. White TJ, Edney JA, Thompson JS, et al. Is there a prognostic difference between functional and nonfunctional islet cell tumors?. Am J Surg. 1994;168:627–629

PII: S0002-9610(07)00013-X

doi: 10.1016/j.amjsurg.2006.10.016

The American Journal of Surgery
Volume 193, Issue 4 , Pages 460-465 , April 2007

Article Tools

* Image Usage & Resolution